Full text is available at the source.
Abstract
Gut microbes may significantly influence drug metabolism and responses in neuroactive medications.
- Pharmacomicrobiomics examines how gut microbiota impacts drug metabolism, efficacy, and safety.
- Dysbiosis can alter drug responses by affecting neurotransmitter production and immune function.
- Variations in the microbiome are associated with different treatment responses in brain disorders.
- Integrating pharmacomicrobiomics into neuropharmacology could lead to more personalized medicine.
- Emerging microbiome-targeted strategies aim to enhance therapeutic effectiveness and minimize side effects in neuropsychiatric and neurodegenerative conditions.
Simplified